CN

State Food and Drug Administration holds information work promotion meeting

release time:2023-10-27|reading:


On October 19, the State Food and Drug Administration held an information work promotion meeting.


The meeting thoroughly studied and implemented Xi's important thoughts on becoming a network power, summarized and exchanged the achievements and experience of drug supervision informatization work, analyzed and judged the situation and problems, and studied and deployed the next stage of informatization work.


State Food and Drug Administration Party Secretary, Director Li Li attended the meeting and spoke, bureau members of the Party group, deputy director Huang Guo, Lei Ping, bureau drug safety director attended the meeting.


The meeting pointed out that information is the multiplier of the effectiveness of drug supervision and the power source of supervision modernization.


In recent years, drug regulatory authorities at all levels adhere to leading the modernization of drug supervision with informatization, and make every effort to consolidate the foundation of informatization work, innovation and deepening of application. Intelligent drug supervision has entered a new stage of accumulation and deepening application from the foundation and column.


We should accurately grasp the situation and tasks we face, strive to deeply integrate information technology into the whole regulatory process and all aspects of supervision, and comprehensively improve the risk control and whole-life cycle supervision capabilities of regulatory departments at all levels.


The meeting stressed that to do a good job in the current and future a period of drug regulation informatization, adhere to new era to xi jinping, the thought of socialism with Chinese characteristics as guidance, earnestly implement the "four most strict" requirements, in accordance with the "overall coordination, business leading, step by step, to pragmatic" the working train of thought, through innovation mechanism, sharing resources, integrated system, deepening application, overall regulatory informatization of the whole system, strive to build "actual combat work, grassroots love, the masses with" information system, to make information become the key to leading the modernization of drug regulation.


The meeting made six aspects of deployment for the next step.


First, strengthen the overall planning of information work, give full play to the leading role of information planning, strengthen the interconnection of the national drug regulatory information system, and further unify the standards of information construction.


Second, deepen the application of information technology in production supervision, support enterprises to strengthen the real-time monitoring of the production process, and deepen the use of information technology to carry out on-site inspection.


Third, the "network management network" should strengthen the supervision of online drug sales, improve the national unified online sales monitoring platform, and urge the third-party platforms to use information technology to fulfill their main management responsibilities.


Fourth, accelerate the improvement of the electronic drug traceability system, expand the coverage of the drug traceability system, accelerate the integration of the traceability information of each link, and connect the industrial chain, risk chain, responsibility chain and supervision chain with the traceability chain.


Fifth, optimize and improve the level of e-government services, improve the information services for the people, provide high-quality and convenient enterprise-related services, and expand professional and efficient evaluation and approval services.


Sixth, firmly guard the bottom line of network security, improve the drug supervision network and data security technology protection system, improve the data security guarantee capability, and strengthen the integrated protection of the whole system.


The meeting required that the national drug administration system should effectively put intelligent supervision in a more prominent strategic position, strengthen work guarantee, and promote the implementation of key tasks.


Strengthen the organization and leadership, establish and improve the multi-department coordination mechanism driven by business needs and supported by information technology.


Pay close attention to the construction of key projects, and accelerate the transformation of information design drawings into construction drawings.


Strengthen the training of digital thinking and digital skills of supervisors, and improve the information application ability of the whole system.


At the meeting, the Information Center of the State Food and Drug Administration introduced the overall situation of the informatization of drug supervision, and the Drug Registration Department, the Drug Supervision Department, the Instrument Examination Center and the Central Procuratorate exchanged experiences.


The main party and responsible comrades of the departments of the State Food and Drug Administration and the directly affiliated units attended the meeting.


Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.


Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.



Tag: Zhushi Pharmacy Shandong Zhushi Pharmacy Zhushi Pharmaceutical Group



HOT


NEW

Home > NEWS > Industry Information

Scan to learn more

Copyright © 2013-2021 Shandong Zhushi Pharmaceutical Group Co., Ltd Copyright Website Map html   鲁ICP备20021214号-8